Marc Laufgraben is an Endocrinology/Metabolic physician affiliated with Christiana Care Health System. OpenAlex indexes 20 publications with 858 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4735 Ogletown Stanton Rd
Map 2 Ste 3201
Newark, DE 197132094
Telephone
302-623-4323Registry record last updated 21 Jul 2022.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20254 payments
- Xeris Pharmaceuticals, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
59.8%GLP-1 receptor agonist18.1%Ozempic53%Trulicity28%Mounjaro15%Rybelsus4%Part D<11 patientsInsulin Analog14.8%Tresiba Flextouch U-10035%Lantus Solostar21%Novolog Flexpen11%Humalog Kwikpen U-1009%Basaglar Kwikpen U-1007%Insulin Lispro Kwikpen U-1006%Fiasp Flextouch5%Toujeo Solostar3%Tresiba Flextouch U-2003%Part D<11 patients+ 7 more classes in this area
Hormonal (systemic)
22.1%l-Thyroxine19%Levothyroxine Sodium83%Synthroid17%Part D≥155 patientsParathyroid Hormone Analog1.3%Forteo55%Teriparatide45%Part D<11 patients+ 3 more classes in this area
Cardiovascular
13.5%Statin8.4%Atorvastatin Calcium67%Rosuvastatin Calcium33%Part D≥55 patientsCholesterol absorption inhibitor1.2%Ezetimibe100%Part D≥16 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- SUN-563 TSH Elevation after Seizure: An Underappreciated Cause of Nonthyroidal Illness Syndrome
Journal of the Endocrine Society
2019 - Mifepristone for Management of <scp>C</scp> ushing's Syndrome
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Nicholas Petrelli, MD
Christiana Care Health System
Anthony Sciscione, DO
Christiana Care Health System
Brian Nam, MD
Christiana Care Health System
Paul Kaminski, MD
Christiana Care Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”